Kate McGonagle

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Michael G Thomas, Kate McGonagle, Paul Rowland, David A Robinson, Peter G Dodd, Isabel Camino-Díaz, Lorna Campbell, Juan Cantizani, Pablo Castañeda, Daniel Conn, Peter D Craggs, Darren Edwards, Liam Ferguson, Andrew Fosberry, Laura Frame, Panchali Goswami, Xiao Hu, Justyna Korczynska, Lorna MacLean, J Julio Martin, Nicole Mutter, Maria Osuna-Cabello, Christy Paterson, Imanol Peña, Erika G Pinto, Caterina Pont, Jennifer Riley, Yoko Shishikura, Frederick R C Simeons, Laste Stojanovski, John Thomas, Karolina Wrobel, Robert J Young, Filip Zmuda, Fabio Zuccotto, Kevin D Read, Ian H Gilbert, Maria Marco, Timothy J Miles, Pilar Manzano, Manu De Rycker
Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors. Journal of medicinal chemistry (2023)
Michael G Thomas, Stephen Brand, Manu De Rycker, Fabio Zuccotto, Iva Lukac, Peter G Dodd, Eun-Jung Ko, Sujatha Manthri, Kate McGonagle, Maria Osuna-Cabello, Jennifer Riley, Caterina Pont, Frederick Simeons, Laste Stojanovski, John Thomas, Stephen Thompson, Elisabet Viayna, Jose M Fiandor, J Julio Martin, Paul G Wyatt, Timothy J Miles, Kevin D Read, Maria Marco, Ian H Gilbert
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis. Journal of medicinal chemistry 64 (9) (2021)

Kate McGonagle.css-eqlu8i{font-size:small;padding-left:4px;}